Results 311 to 320 of about 112,427 (348)

Hypersensitivity syndrome due to 2 anticonvulsant drugs

Contact Dermatitis, 1999
Drug‐induced hypersensitivity syndrome is a multiorgan‐system reaction characterized by fever, pleomorphic eruption, lymphadenopathy, eosinophilia, lymphocytosis and hepatitis. We report a drug hypersensitivity syndrome in a 6‐year‐old Tunisian child treated for epileptic absences with sodium valproate and ethosuximide. Imputability of these 2 drugs is
V, Conilleau, A, Dompmartin, L, Verneuil, M, Michel, D, Leroy   +4 more
openaire   +2 more sources

Drug Eruptions and Hypersensitivity Syndromes

2016
Drug eruptions and hypersensitivity reactions are commonly encountered diagnoses in inpatient pediatric dermatology and can range from simple cutaneous eruptions to severe, life-threatening systemic reactions. Although etiology varies by diagnosis, these reactions are most often triggered by medication exposure and/or infectious agents. In this chapter,
Nicole N. Harter, Minnelly Luu
openaire   +1 more source

New aspects of drug‐induced hypersensitivity syndrome

The Journal of Dermatology, 2011
AbstractDrug‐induced hypersensitivity syndrome (DIHS) is caused by a limited number of specific drugs and is characterized by late onset, infectious mononucleosis‐like symptoms, and herpesvirus 6 (HHV‐6) reactivation. Recently, the involvement of herpes viruses other than HHV‐6, such as Epstein–Barr virus and cytomegalovirus, has been reported.
Mikiko, Tohyama, Koji, Hashimoto
openaire   +2 more sources

Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome

Respiratory Investigation, 2012
Here, we report 2 cases of drug-induced hypersensitivity syndrome (DIHS) caused by salazosulfapyridine and allopurinol during tuberculosis treatment. Both patients also developed multiple drug hypersensitivity (MDH) to several antituberculosis drugs that were used at around the period of DIHS onset, and thus, the treatment could not be successfully ...
Akimasa, Sekine, Takefumi, Saito, Shusaku, Ito, Yoshiya, Tsunoda, Yuki, Sumazaki, Toru, Tanaka, Hiroyuki, Takoi, Shih-Yuan, Lin, Yohei, Yatagai, Kenji, Hayasihara   +9 more
openaire   +2 more sources

Testing for drug hypersensitivity syndromes.

The Clinical biochemist. Reviews, 2013
Adverse drug reactions are a common cause of patient morbidity and mortality. Type B drug reactions comprise only 20% of all drug reactions but they tend to be primarily immunologically mediated and less dependent on the drug's pharmacological action and dose.
Rive, C.M., Bourke, J., Phillips, E.J.
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Chiara Corti   +2 more
exaly  

Drug Hypersensitivity Syndrome

2021
openaire   +1 more source

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

International Journal of Molecular Sciences, 2021
Fumi Miyagawa, Hideo Asada
exaly  

Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis

Journal of Allergy and Clinical Immunology: in Practice, 2022
Natsumi Hama, Andrew Gibson, Riichiro Abe   +2 more
exaly  

Case of drug‐induced hypersensitivity syndrome involving multiple‐drug hypersensitivity

The Journal of Dermatology, 2012
Kohei OGAWA, Hironori MORITO, Nobuhiko KOBAYASHI, Takaya FUKUMOTO, Hideo ASADA   +4 more
openaire   +1 more source